ZOM — Zomedica Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapNeutral
- $194.03m
- $74.56m
- $18.93m
- 20
- 39
- 51
- 28
Annual balance sheet for Zomedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.94 | 0.511 | 62 | 195 | 115 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.054 | 0.068 | 0.146 | 0.765 | 1.86 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 3.86 | 1.81 | 62.9 | 200 | 124 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.717 | 1.83 | 1.9 | 2.53 | 9.17 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 6.03 | 4.18 | 66.1 | 280 | 280 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.38 | 2.09 | 2.03 | 4.34 | 7.81 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.38 | 2.09 | 3.12 | 9.51 | 12.2 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3.66 | 2.1 | 63 | 271 | 267 |
| Total Liabilities & Shareholders' Equity | 6.03 | 4.18 | 66.1 | 280 | 280 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |